关键词:
hepatitis B virus
single nucleotide polymorphism
zinc finger protein 350
Peg-IFN alpha
therapeutic effect
摘要:
Background: The varying individual responses to Pegylated interferon-alpha (Peg-IFN alpha) in patients with chronic hepatitis B (CHB) pose significant hurdles in treatment optimization, and the underlying mechanisms remain unclear. Objective: We aimed to identify genetic polymorphisms influencing the efficacy of Peg-IFN alpha in patients with HBeAg-positive CHB, with the goal to predict Peg-IFN alpha response before treatment. Methods: We employed an Asian Screening Array analysis involving 124 HBeAg-positive CHB patients treated with Peg-IFN alpha. We conducted assessment of immunological markers and mRNA expression of pivotal genes, establishing correlations with SNPs, functional genes of SNPs, and efficacy of Peg-IFN alpha therapy. In vitro experiments were performed to verify the functional involvement of the candidate SNPs. Results: The G allele presented in rs2278420 and rs6509607 were significantly more common in patients who achieved a complete response (CR) compared to those who had a suboptimal response (SR), and linked to an increased rates of HBeAg loss following Peg-IFN alpha treatment (all p < 0.05). Additionally, the mRNA level of ZNF350 varied notably across different genotypes of both SNPs as determined by eQTL analysis, and showed higher expression in patients achieved a SR (all p < 0.05). In vitro investigations with IFN alpha stimulation showed that the mRNA level of SOCS3 was elevated in patients with rs2278420 genotype AA, similarly, mRNA levels of PKR, STAT2, SOCS1, SOCS3, PIAS1, PTPN6 and TRIM8 were heightened in patients with rs6509607 genotype AA compared to those with genotypes (AG+GG) (all p < 0.05). Conclusion: The G allele of rs2278420 and rs6509607 were associated with mRNA level of ZNF350, with an increased probability of Peg-IFN alpha response in HBeAg-positive CHB patients, likely through the modulation of JAK-STAT signaling pathway.